4,653 research outputs found

    What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary

    No full text
    The aim of this commentary is to discuss the published Cochrane Review “Belimumab for systemic lupus erythematosus”1 by Singh et al.,a under the direct supervision of Cochrane Musculoskeletal Group. This Cochrane Corner is produced in agreement with International Journal of Rheumatic Diseases by Cochrane Rehabilitation
    corecore